Patents by Inventor Jera Lewis

Jera Lewis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF DETERMINING PATIENT POPULATIONS AMENABLE TO IMMUNOMODULATORY TREATMENT OF CANCER
    Publication number: 20220187299
    Abstract: The disclosure provides methods of determining patient populations amenable or suitable for immunomodulatory treatment of disease such as cancer by measuring the relative or absolute levels of T-cell sub-populations correlated with disease such as cancer.
    Type: Application
    Filed: November 29, 2021
    Publication date: June 16, 2022
    Inventors: Lawrence Fong, Serena Kwek MacPhee, Jera Lewis
  • Methods of determining patient populations amenable to immunomodulatory treatment of cancer
    Patent number: 11215616
    Abstract: The disclosure provides methods of determining patient populations amenable or suitable for immunomodulatory treatment of disease such as cancer by measuring the relative or absolute levels of T-cell sub-populations correlated with disease such as cancer.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: January 4, 2022
    Assignee: NATIONAL INSTITUTES OF HEALTH (NIH), (DHHS), U.S. GOVERNMENT
    Inventors: Lawrence Fong, Serena Kwek MacPhee, Jera Lewis
  • Methods of Determining Patient Populations Amenable to Immunomodulatory Treatment of Cancer
    Publication number: 20180074058
    Abstract: The disclosure provides methods of determining patient populations amenable or suitable for immunomodulatory treatment of disease such as cancer by measuring the relative or absolute levels of T-cell sub-populations correlated with disease such as cancer.
    Type: Application
    Filed: April 8, 2016
    Publication date: March 15, 2018
    Inventors: Lawrence Fong, Serena MacPhee, Jera Lewis